BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen YC, Hsu HC, Lin TM, Chang YS, Hu LF, Chen LF, Lin SH, Kuo PI, Chen WS, Lin YC, Chen JH, Liang YC, Chang CC. H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection. J Clin Oncol 2022;:JCO2101802. [PMID: 35044851 DOI: 10.1200/JCO.21.01802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Brockmueller A, Mueller A, Kunnumakkara AB, Aggarwal BB, Shakibaei M. Multifunctionality of Calebin A in inflammation, chronic diseases and cancer. Front Oncol 2022;12:962066. [DOI: 10.3389/fonc.2022.962066] [Reference Citation Analysis]
2 Chen Z, Lin X, Wan Z, Xiao M, Ding C, Wan P, Li Q, Zheng S. High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma. Genes 2022;13:876. [DOI: 10.3390/genes13050876] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chang R, Chen HY, Hung YM, Wei JC. Correspondence on Concerns About Methodology and Confounding. J Clin Oncol 2022;:JCO2200237. [PMID: 35549511 DOI: 10.1200/JCO.22.00237] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chang YS, Shen YC, Chen JH, Chang CC. Reply to C.-H. Chiang et al and R. Chang et al. J Clin Oncol 2022;:JCO2200711. [PMID: 35549388 DOI: 10.1200/JCO.22.00711] [Reference Citation Analysis]
5 Chiang CH, Chiang CH, Chiang CH. Are H1-Antihistamines Associated With a Lower Risk of Hepatocellular Carcinoma? J Clin Oncol 2022;:JCO2200179. [PMID: 35549455 DOI: 10.1200/JCO.22.00179] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]